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SUMMARY. Powder mixtures (1:1) of tibolone polymorphic forms I (monoclinic) and II (triclinic) and ex-
cipients have been prepared and compacted. The samples were stored at 50 °C and 90% RH for one
month and subsequently were evaluated using differential scanning calorimetry (DSC) and high-perfor-
mance liquid chromatography (HPLC). The results indicate that during the compaction, the applied pres-
sure reduced the chemical stability of tibolone in both polymorph forms. The triclinic form was more
chemically unstable, both pure and in contact with excipients, than the monoclinic form. Lactose monohy-
drate was shown to reduce chemical degradation for both forms. Ascorbyl palmitate was shown to affect
the tibolone stability differently depending on the polymorphic form used.
